Clinical Trials Browser

Phase 2 × Anxiety Disorders × Citalopram × Clear all

NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Phase 2 Completed

Anxiety Disorders, Depression, Lymphoma, Follicular